Skip to content

LivaNova LIVN PP&E (Net)

PP&E (Net) at other companies

Abbott logo
AbbottABT
$12.38B+13.2%
Haemonetics logo
HaemoneticsHAE
$305.76M+7.6%
Medtronic logo
MedtronicMDT
$7.42B+8.5%
ITG
Integer HoldingsITGR
$533.14M+7.5%
ResMed logo
ResMedRMD
$566.97M+5.9%
Boston Scientific logo
Boston ScientificBSX
$4.06B+19.9%

Segments

By geography

See full
Italy$73.7M
United States$65.17M

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's PP&E (net)?
LivaNova (LIVN) reported PP&E (net) of $255.48M in Q1 2026.
How has LivaNova's PP&E (net) changed year-over-year?
LivaNova's PP&E (net) increased by 43.8% year-over-year, from $177.68M to $255.48M.
What is the long-term trend for LivaNova's PP&E (net)?
Over 5 years (2020 to 2025), LivaNova's PP&E (net) has grown at a 8.2% compound annual growth rate (CAGR), from $163.81M to $242.6M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.